Tonic Clonic Seizure In Patients With Epilepsy — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for tonic clonic seizure in patients with epilepsy. 9 active patents protecting 1 drugs from 1+ originators. First major cliff: 2040. Daily refresh.

1
Approved drugs
9
Active US patents
73/100
Avg vulnerability
—
Annual revenue covered

Originators in Tonic Clonic Seizure In Patients With Epilepsy

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

UCB 9 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating tonic clonic seizure in patients with epilepsy. Each bar = one year. Y-axis scaled to peak year (9 patents).

9
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Vimpat
lacosamide
 UCB 9 73 — 2040-06-05

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11883374 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
11337943 Vimpat method of use 70 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
12042474 Vimpat method of use 75 2040-06-05
11883374 Vimpat method of use 75 2040-06-05

Related